Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada

No abstract available.

Information

Citation

Kuenzig ME, Widdifield J, Bernatsky S, Kaplan GG, Benchimol EI. Lancet Gastroenterol Hepatol. 2022; 7(4):288-9. Epub 2022 Feb 22.

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Sites

ICES Central

Discover More

Journal Article

Comparing outcomes of ureteric stent versus nephrostomy tube in urosepsis: a population-based study in Ontario, Canada

Elmansy H, Berjaoui MB, Savage DW, Cerasuolo JO, Lalva T, Mckay R, Zakaria AS. World J Urol. 2025; 43(1):692.

Journal Article

A population-based matched cohort study of extra-digestive cancer incidence and mortality in individuals with and without inflammatory bowel disease

Murthy SK, Ahmed F, Pugliese M, Taljaard M, Tandon P, Matthews P, Kaplan GG, Coward S, Bernstein CN, Benchimol EI, Kuenzig ME, Targownik LE, Singh H; Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC). Aliment Pharmacol Ther. 2025; Nov 11 [Epub ahead of print].

Journal Article

Risk for scrotal surgery after laparoscopic donor nephrectomy: a population-based cohort study

Garg AX, McArthur E, Sontrop JM, Boudville N, Connaughton DM, Cuerden MS, Feldman LS, Lam NN, Lentine KL, Nguan C, Parikh CR, Segev DL, Sener A, Smith G, Wang C, Weir MA, Yohanna S, Young A, Naylor KL. Ann Intern Med. 2025; Nov 11 [Epub ahead of print].